Literature DB >> 21108607

Correlation of cell cycle regulatory proteins (p53 and p16(ink)⁴(a)) and bcl-2 oncoprotein with mitotic index and thickness of primary cutaneous malignant melanoma.

Miloš Kostov1, Zaklina Mijović, Dragan Mihailović, Snežana Cerović, Miroslav Stojanović, Marija Jelić.   

Abstract

The purpose of the study was to determine the frequency of expression p53 and p16INK4a proteins and bcl-2 oncoprotein in malignant skin melanoma and to determine their correlation with the proliferative index and tumor thickness. The study involved 53 patients: 27 (51%) male and 26 (49%) female. Mitotic index showed a correlation with p53 protein expression, a negative correlation with p16INK4a protein expression. Statistically significant correlations were determined between the Breslow tumor thickness, Clark invasion level and p53 protein expression, as well as Breslow tumor thickness and bcl-2 oncoprotein expression (p<0.05), whereas there was no correlation between the p16INK4a protein expression and melanoma thicknes and Clark invasion level. Overexpression p53 protein and bcl-2 oncoprotein, with the loss p16INK4a protein of expression in the nodular melanoma, confirms a frequent loss of function of these tumor suppressor gene and oncogene, and indicates a vertical tumor growth phase. The loss of tumor suppression function the p53 protein and bcl-2 oncoprotein overexpression in cutaneous melanoma correlates with larger tumor thickness, whereas the overexpression of mutated p53 protein and loss p16INK4a protein of expression indicate a higher proliferative tumour potential. Therefore, these evaluated proteins may be the aggressive biological tumour activity markers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108607      PMCID: PMC5489034          DOI: 10.17305/bjbms.2010.2660

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  28 in total

Review 1.  The molecular basis of melanomagenesis and the metastatic phenotype.

Authors:  A Neil Crowson; Cynthia Magro; Arlo Miller; Martin C Mihm
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

2.  The role of cell cycle regulatory proteins in the pathogenesis of melanoma.

Authors:  Wei Li; Amira Sanki; Rooshdiya Z Karim; John F Thompson; C Soon Lee; Liqing Zhuang; Stanley W McCarthy; Richard A Scolyer
Journal:  Pathology       Date:  2006-08       Impact factor: 5.306

3.  Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin.

Authors:  L Talve; J Kainu; Y Collan; T Ekfors
Journal:  Pathol Res Pract       Date:  1996-08       Impact factor: 3.250

4.  p16 expression in primary malignant melanoma is associated with prognosis and lymph node status.

Authors:  Daniela Mihic-Probst; Christian D Mnich; Patrick A Oberholzer; Burkhardt Seifert; Bernd Sasse; Holger Moch; Reinhard Dummer
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

5.  Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma.

Authors:  O Straume; L Sviland; L A Akslen
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

Review 6.  Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas.

Authors:  Mateja Legan
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

Review 7.  Malignant melanoma in the 21st century: the emerging molecular landscape.

Authors:  Aleksandar Sekulic; Paul Haluska; Arlo J Miller; Josep Genebriera De Lamo; Samuel Ejadi; Jose S Pulido; Diva R Salomao; Erik C Thorland; Richard G Vile; David L Swanson; Barbara A Pockaj; Susan D Laman; Mark R Pittelkow; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2008-07       Impact factor: 7.616

8.  p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry.

Authors:  L E Sparrow; M J Eldon; D R English; P J Heenan
Journal:  Am J Dermatopathol       Date:  1998-06       Impact factor: 1.533

9.  Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.

Authors:  J A Reed; F Loganzo; C R Shea; G J Walker; J F Flores; J M Glendening; J K Bogdany; M J Shiel; F G Haluska; J W Fountain
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

10.  Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi.

Authors:  M C Saenz-Santamaría; J A Reed; N S McNutt; C R Shea
Journal:  J Cutan Pathol       Date:  1994-10       Impact factor: 1.587

View more
  3 in total

1.  Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck.

Authors:  Manju L Prasad; Snehal G Patel; Jatin P Shah; Stacy Hoshaw-Woodard; Klaus J Busam
Journal:  Head Neck Pathol       Date:  2011-12-13

2.  Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma.

Authors:  Serkan Senol; Asif Yildirim; Bahar Ceyran; Fatih Uruc; Ebru Zemheri; Seyma Ozkanli; Ibrahim Akalin; Ismail Ulus; Turhan Caskurlu; Abdullah Aydin
Journal:  Bosn J Basic Med Sci       Date:  2015-08-19       Impact factor: 3.363

3.  Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?

Authors:  Daniela Göppner; Martin Leverkus
Journal:  J Skin Cancer       Date:  2011-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.